Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 467
Immune Disorders Drugs 194
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 124
Drug Discovery 107
Central Nervous System Drugs 106
Endocrine and Metabolic Disorders Drugs 103
Clinical Trials 98
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 89
Leukemia Drugs 83
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 33
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 26
Analgesics 26
Drugs by Therapeutic Area 24
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Prostate Cancer Drugs 17
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,397 Results (Page 75 of 120)
- Relevance
  Sort by

Malignant Mesothelioma - Global Strategic Business Report

 Report
December 2025
193 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Precision Oncology Market - Global Strategic Business Report

 Report
December 2025
382 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Esophageal Cancer Drugs - Global Strategic Business Report

 Report
December 2025
269 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Adrenocortical Carcinoma Treatment - Global Strategic Business Report

 Report
December 2025
289 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Chemotherapy Treatment - Global Strategic Business Report

 Report
December 2025
188 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cytotoxic Drugs - Global Strategic Business Report

 Report
December 2025
462 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Cellular Immunotherapy - Global Strategic Business Report

 Report
December 2025
386 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Neuroendocrine Tumor Treatment - Global Strategic Business Report

 Report
December 2025
383 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Head and Neck Cancer Therapeutics - Global Strategic Business Report

 Report
December 2025
183 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Cancer Immunotherapy - Global Strategic Business Report

 Report
December 2025
291 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Urothelial Cancer Drugs - Global Strategic Business Report

 Report
December 2025
126 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Neuroendocrine Tumors Therapeutics - Global Strategic Business Report

 Report
December 2025
171 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors - Global Strategic Business Report

 Report
December 2025
275 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Testicular Cancer Drugs - Global Strategic Business Report

 Report
December 2025
269 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Small Molecules Drugs for Inflammatory Bowel Diseases Market - Global Forecast 2025-2030

 Report
August 2025
197 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

Bacterial Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€3965EUR$4,500USD£3,483GBP

Cancer Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Large B-Cell Lymphoma, Multiple Myeloma), By Vector Type (Lentivirus, RetroVirus & Gamma RetroVirus, AAV), By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030

 Report
June 2025
120 Pages
Global

From

€5243EUR$5,950USD£4,605GBP

Effervescent Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
July 2025
210 Pages
Global

From

€4402EUR$4,995USD£3,866GBP

LAMEA Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

 Report
January 2024
109 Pages
Middle East, Africa

From

€1322EUR$1,500USD£1,161GBP

Europe Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

 Report
January 2024
108 Pages
Europe

From

€1322EUR$1,500USD£1,161GBP

2,397 Results (Page 75 of 120)
- 1
- 73
- 74
- 75
- 76
- 77

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.